Spire Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
GAM
Spire Wealth Management's SBIO Position: Q2 2026 in Review
Spire Wealth Management held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 53 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.
Spire Wealth Management first reported a position in SBIO in Q4 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Spire Wealth Management held 53 shares of ALPS Medical Breakthroughs ETF worth $3.43K as of Q2 2026.
- Spire Wealth Management left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1902 holding.
- Spire Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and has held it in 3 quarters since.
- 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.